This is a discussion on Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin within the FDA News forum, part of the Industry News and Updates category; FDA has required the manufacturers of the smoking cessation aids varenicline (Chantix) and bupropion (Zyban and generics) to add new ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
FDA has required the manufacturers of the smoking cessation aids varenicline (Chantix) and bupropion (Zyban and generics) to add new Boxed Warnings and develop patient Medication Guides highlighting the risk of serious neuropsychiatric symptoms in patients using these products. 7/1/2009
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Information for Healthcare Professionals: Cefepime (marketed as Maxipime) | industry_news | FDA News | 0 | 06-17-2009 12:00 PM |
| Efalizumab (marketed as Raptiva) Information | industry_news | FDA News | 0 | 04-08-2009 11:55 PM |
| FDA issues an Information for Healthcare Professionals sheet for antipsychotics | industry_news | FDA News | 0 | 06-16-2008 06:05 PM |
| FDA approves new Medication Guide and Label for Varenicline (marketed as Chantix) | industry_news | FDA News | 0 | 05-19-2008 03:47 PM |
| FDA updates information to healthcare facilities and healthcare professionals about heparin and heparin-containing medic | industry_news | FDA News | 0 | 04-25-2008 11:59 PM |